Skip to content

Behavioural Brain Research

ISSN 1872-7549

60 papers in the library · 1,076 citations · publishing 1994-2026

Papers

Sort Most recent Most cited

Recovery sleep after sleep deprivation almost completely abolishes dream recall.

Behavioural Brain Research January 20, 2010 Luigi De Gennaro, Cristina Marzano, Fabio Moroni et al.

The study investigated the effect of one night of sleep deprivation on dream recall at morning awakening after recovery sleep. Forty healthy subjects were studied after adaptation (A) and baseline nights (B), and a recovery (R) night following 40 h of prolonged wakefulness. Parallel to the well-known recovery sleep changes (slow-wave sleep--SWS--rebound, decreased number of awakenings and of...

Phencyclidine-induced locomotor hyperactivity is enhanced in mice after stereotaxic brain serotonin depletion.

Behavioural Brain Research August 22, 2008 Sally Martin, Maarten Van den Buuse

The aim of this study was to investigate the role of forebrain serotonin projections in behavioural models with relevance to schizophrenia. Mice received stereotaxic micro-injections of the serotonin neurotoxin 5,7-dihydroxytryptamine into the median raphe nucleus (MRN). Two weeks later, MRN-lesioned mice were hyperactive at baseline and showed enhanced locomotor hyperactivity induced by...

Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/cJ) with different hippocampal NMDA receptor densities.

Behavioural Brain Research January 6, 2006 Rainer Wolf, Henrik Dobrowolny, Kay Matzke et al.

The hypo-glutamatergic hypothesis of schizophrenia is not only based on the phencyclidine-(PCP)-induced psychosis in mentally healthy humans but also on studies with schizophrenic patients showing deficits in post mortem hippocampal N-methyl-d-aspartate (NMDA) receptor gene expression and deficits in prepulse inhibition. The inbred mouse strains CPB-K and BALB/cJ display considerable...

Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.

Behavioural Brain Research August 31, 2004 John Mastropaolo, Richard B Rosse, Stephen I Deutsch

The expression of the alpha7-nicotinic acetylcholine receptor is diminished in selected brain areas of patients with schizophrenia. This diminished expression may account for the pathophysiological deficits of sensory inhibition and smooth pursuit eye movement performance in these patients. Furthermore, the deficits in sensory inhibition and smooth pursuit eye movement performance in...

Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction.

Behavioural Brain Research December 1, 1997 J R Blackburn, Karen K. Szumlinski 22 citations

The neural basis of ibogaine's effects on drug-related behaviours is unclear. One possibility is that ibogaine interferes with the shared capacity of many addictive agents to stimulate brain dopamine activity, but reports of ibogaine effects on dopamine activity have been inconsistent. Our study suggests such inconsistencies may result from variations in prior drug exposure. If ibogaine blocks...

Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience.

Behavioural Brain Research May 1, 1996 S M Netto, F S Guimarães 45 citations

Previous studies have shown that 2 h restraint stress induces deficits in open arm exploration of an elevated plus maze 24 h later. This effect was attenuated by a post-stress systemic injection of the 5-HT non-selective agonist, 5-methoxy-N,N-dimethyltryptamine (5-MeODMT). To verify a possible involvement of hippocampal 5-HT1A receptors in this effect, rats were stereotaxically implanted with...

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis.

Behavioural Brain Research 1996 R E Steinpreis

Phencyclidine (PCP) produces a psychotic reaction in humans which closely resembles an acute episode of schizophrenia and has therefore been given an increasing amount of attention as a model for schizophrenia. The present article reviews the behavioral and neurochemical effects of PCP in both humans and animals. Where possible, comparisons are made between the effects of PCP and amphetamine....

Human psychopharmacology of N,N-dimethyltryptamine

Behavioural Brain Research December 1, 1995 Rick J. Strassman 257 citations

We generated dose-response data for the endogenous and ultra-short-acting hallucinogen, N,N-dimethyltryptamine (DMT), in a cohort of experienced hallucinogen users, measuring multiple biological and psychological outcome measures. Subjective responses were quantified with a new rating scale, the HRS, which provided better resolution of dose effects than did the biological variables. A tolerance...

Visual perception and phenomenal consciousness.

Behavioural Brain Research November 1, 1995 P Stoerig, A Cowey 54 citations

In the (re-)animated debate on consciousness we focus on three questions: Who has consciousness? What is its neuronal basis? What is its function? Regarding the first, we suggest that consciousness is exclusive to living organisms able to distinguish self from non-self. It may be restricted further to organisms who possess a repertoire of overt and covert behaviour which can be voluntarily...

The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine.

Behavioural Brain Research November 16, 1994 S L Cappendijk, D Fekkes, M R Dzoljic 57 citations

Norharman (20 mg/kg, i.p.) and ibogaine (40 mg/kg, i.p.) significantly attenuated naloxone (4 mg/kg, i.p.)-precipitated withdrawal syndrome in morphine-dependent rats. Several withdrawal signs, such as teeth-chattering, chewing, penile licking and diarrhoea, were decreased by both norharman and ibogaine. In addition, norharman reduced also the withdrawal grooming and rearing. It is concluded...